Article contents
Treatment of depression in an adolescent with cardiomyopathy and arrhythmia
Published online by Cambridge University Press: 17 November 2014
Abstract
Patients with cardiomyopathy have a higher incidence of mood and anxiety disorders, resulting in greater probability for hospitalisation and increased risk for arrhythmia and death. We report a case of a 16-year-old boy with Danon disease, Wolff–Parkinson–White syndrome, and hypertrophic cardiomyopathy, who later developed depression and significant weight loss. The patient was successfully treated for his anxiety and depression with mirtazapine without any adverse cardiac effects.
- Type
- Brief Reports
- Information
- Copyright
- © Cambridge University Press 2014
References
1.
Wang, Q, Hay, M, Clarke, D, Menahem, S. The prevalence and predictors of anxiety and depression in adolescents with heart disease. J Pediatr
2012; 161: 943–946.CrossRefGoogle ScholarPubMed
2.
Hamang, A, Eide, GE, Rokne, B, Nordin, K, Oyen, N. General anxiety, depression, and physical health in relation to symptoms of heart-focused anxiety – a cross sectional study among patients living with the risk of serious arrhythmias and sudden cardiac death. Health Qual Life Outcomes
2011; 9: 100.CrossRefGoogle ScholarPubMed
3.
Menteer, J, Beas, VN, Chang, JC, Reed, K, Gold, JI. Mood and health-related quality of life among pediatric patients with heart failure. Pediatr Cardiol
2013; 34: 431–437.CrossRefGoogle ScholarPubMed
4.
Harris, J, Heil, JS. Managing depression in patients with advanced heart failure awaiting transplantation. Am J Health Syst Pharm
2013; 70: 867–873.CrossRefGoogle ScholarPubMed
5.
Miani, D, Taylor, M, Mestroni, L, et al. Sudden death associated with danon disease in women. Am J Cardiol
2012; 109: 406–411.CrossRefGoogle ScholarPubMed
6.
Boucek, D, Jirikowic, J, Taylor, M. Natural history of Danon disease. Genet Med
2011; 13: 563–568.CrossRefGoogle ScholarPubMed
7.
Wan, DD, Kundhur, D, Solomons, K, Yatham, LN, Lam, RW. Mirtazapine for treatment-resistant depression: a preliminary report. J Psychiatry Neurosci
2003; 28: 55–59.Google ScholarPubMed
8.
Waring, WS, Graham, A, Gray, J, Wilson, AD, Howell, C, Bateman, DN. Evaluation of a QT nomogram for risk assessment after antidepressant overdose. Br J Clin Pharmacol
2010; 70: 881–885.CrossRefGoogle ScholarPubMed
9.
Leonard, CE, Bilker, WB, Newcomb, C, Kimmel, SE, Hennessy, S. Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia. Pharmacoepidemiol Drug Saf
2011; 20: 903–913.CrossRefGoogle ScholarPubMed
- 4
- Cited by